Ryan J. Selhorn - 11 Nov 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Ryan J. Selhorn
Issuer symbol
AYTU
Transactions as of
11 Nov 2024
Net transactions value
$0
Form type
4
Filing time
13 Nov 2024, 16:10:22 UTC
Next filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +14,000 +739% $0.000000 15,895 11 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock which vest as follows: One-third on November 11, 2025; 1/12th of the original grant quarterly thereafter through November 11, 2027.